Study shows association between climate change and eye maladies
Clinical visits by patients suffering ocular surface eye conditions more than doubled during times when ambient particulate ...
ophthalmologyadvisor1d
Photobiomodulation Treatment Receives FDA Authorization for Dry AMD Therapy
The Valeda ® Light Delivery System (LumiThera, Inc.) is the first ever FDA-authorized treatment for vision loss in dry AMD, the manufacturer reported. The technology was evaluated in the LIGHTSITE III ...
Science Daily2d
Slow editing of protein blueprints leads to cell death
The study sheds light on how specific mutations may lead to the retinal disease retinitis pigmentosa. Importantly, these findings could also open the door to new diagnostic tests and treatments for a ...
Frontiers2d
Advances in Ocular Autoimmune Diseases
Common ocular autoimmune diseases include thyroid eye disease, orbital inflammatory pseudotumor ... prevention, diagnosis, and treatment. This Research Topic aims to explore advancements in the ...
Medscape4d
Researchers Identify Why Some Don’t Respond to Anti-VEGF Drugs for AMD
Hopkins researchers are further investigating 32-134D in wet AMD and diabetic eye disease, as well as other blinding diseases ...
Treatment to preserve sight in children with rare genetic disorder shows promise in clinical trial
A new treatment that could prevent blindness in children with the CLN2 type Batten disease has been trialed by clinicians and ...
GlobalData on MSN5d
FDA delays priority review of Neurotech’s eye cell therapy implant
The US regulatory agency has pushed the PDUFA date by three months to 18 March 2025 to “allow for more time to review ...
New Atlas7d
RNA therapy an effective alternative to lifelong, painful eye injections
An RNA-editing gene therapy has been developed that switches off the key driver of common eye conditions affecting diabetics ...
How Luminopia Uses VR To Make Amblyopia Treatment Accessible To Every Child
On its website, the company says coping with amblyopia is "tough enough"—but getting treated for it doesn’t have to be.
Science Daily8d
Why some patients don't respond well to wet macular degeneration treatment
A new study explains not only why some patients with wet age-related macular degeneration (or 'wet' AMD) fail to have vision improvement with treatment, but also how an experimental drug could be used ...
Alzheimer's Research UK14d
New Alzheimer’s treatments
These are known as disease-modifying treatments. One of these, lecanemab, has been licensed for private use. Other medications are under review to see if they could be prescribed to people in the very ...